NO20032769L - Kombinasjonsmetode for behandling av virale infeksjoner - Google Patents
Kombinasjonsmetode for behandling av virale infeksjonerInfo
- Publication number
- NO20032769L NO20032769L NO20032769A NO20032769A NO20032769L NO 20032769 L NO20032769 L NO 20032769L NO 20032769 A NO20032769 A NO 20032769A NO 20032769 A NO20032769 A NO 20032769A NO 20032769 L NO20032769 L NO 20032769L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- viral infections
- combination method
- combination
- infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25665700P | 2000-12-19 | 2000-12-19 | |
PCT/US2001/048802 WO2002056902A2 (en) | 2000-12-19 | 2001-12-17 | Ccr5 antagonist and dp-178 polypeptide for treating viral infections |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20032769D0 NO20032769D0 (no) | 2003-06-18 |
NO20032769L true NO20032769L (no) | 2003-08-18 |
Family
ID=22973061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20032769A NO20032769L (no) | 2000-12-19 | 2003-06-18 | Kombinasjonsmetode for behandling av virale infeksjoner |
Country Status (12)
Country | Link |
---|---|
US (1) | US20050065319A1 (no) |
EP (1) | EP1385534A2 (no) |
JP (1) | JP2005500981A (no) |
CN (1) | CN1481251A (no) |
AR (1) | AR031931A1 (no) |
BR (1) | BR0116253A (no) |
CA (1) | CA2431919A1 (no) |
HU (1) | HUP0302241A3 (no) |
MX (1) | MXPA03005526A (no) |
NO (1) | NO20032769L (no) |
WO (1) | WO2002056902A2 (no) |
ZA (1) | ZA200304560B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2400553A (en) * | 2003-04-14 | 2004-10-20 | Cipla Ltd | Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof |
RU2353357C2 (ru) * | 2003-05-16 | 2009-04-27 | Юниверсити Оф Мэрилэнд Байотекнолоджи Инститьют | Композиции для супрессии экспрессии ccr5 и способы их применения |
CA2587903A1 (en) | 2004-11-17 | 2006-05-26 | Amgen Fremont Inc. | Fully human monoclonal antibodies to il-13 |
WO2007064620A2 (en) * | 2005-11-30 | 2007-06-07 | Schering Corporation | Compositions comprising a combination of ccr5 and cxcr4 antagonists |
EP1976497A2 (en) * | 2005-12-01 | 2008-10-08 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Treatment of viral infections |
EP1886696A1 (en) * | 2006-08-03 | 2008-02-13 | Endotis Pharma | Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins |
WO2013127299A1 (zh) * | 2012-02-28 | 2013-09-06 | 中国人民解放军军事医学科学院毒物药物研究所 | 用于抑制hiv的多肽及其作用靶点 |
US11629196B2 (en) | 2020-04-27 | 2023-04-18 | Incelldx, Inc. | Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5464933A (en) * | 1993-06-07 | 1995-11-07 | Duke University | Synthetic peptide inhibitors of HIV transmission |
CA2224008C (en) * | 1995-06-07 | 2009-08-18 | Trimeris, Inc. | The treatment of hiv and other viral infections using combinatorial therapy |
US6281331B1 (en) * | 1998-03-23 | 2001-08-28 | Trimeris, Inc. | Methods and compositions for peptide synthesis |
US6387930B1 (en) * | 1999-05-04 | 2002-05-14 | Schering Corporation | Piperidine derivatives useful as CCR5 antagonists |
DK1175402T3 (da) * | 1999-05-04 | 2005-11-21 | Schering Corp | Piperidinderivater, der er nyttige som CCR5-antagonister |
CN1349408A (zh) * | 1999-05-04 | 2002-05-15 | 先灵公司 | 聚乙二醇化干扰素α-CCR5拮抗剂联合HIV疗法 |
US6391865B1 (en) * | 1999-05-04 | 2002-05-21 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
US6689765B2 (en) * | 1999-05-04 | 2004-02-10 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
-
2001
- 2001-06-11 US US10/168,295 patent/US20050065319A1/en not_active Abandoned
- 2001-12-17 EP EP01993303A patent/EP1385534A2/en not_active Withdrawn
- 2001-12-17 MX MXPA03005526A patent/MXPA03005526A/es unknown
- 2001-12-17 JP JP2002557409A patent/JP2005500981A/ja active Pending
- 2001-12-17 HU HU0302241A patent/HUP0302241A3/hu unknown
- 2001-12-17 AR ARP010105840A patent/AR031931A1/es unknown
- 2001-12-17 BR BRPI0116253-5A patent/BR0116253A/pt not_active IP Right Cessation
- 2001-12-17 CA CA002431919A patent/CA2431919A1/en not_active Abandoned
- 2001-12-17 CN CNA01820919XA patent/CN1481251A/zh active Pending
- 2001-12-17 WO PCT/US2001/048802 patent/WO2002056902A2/en not_active Application Discontinuation
-
2003
- 2003-06-11 ZA ZA2003/04560A patent/ZA200304560B/en unknown
- 2003-06-18 NO NO20032769A patent/NO20032769L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0302241A3 (en) | 2005-06-28 |
WO2002056902A3 (en) | 2002-12-05 |
NO20032769D0 (no) | 2003-06-18 |
WO2002056902A2 (en) | 2002-07-25 |
HUP0302241A2 (hu) | 2003-11-28 |
BR0116253A (pt) | 2006-05-02 |
EP1385534A2 (en) | 2004-02-04 |
US20050065319A1 (en) | 2005-03-24 |
ZA200304560B (en) | 2005-07-27 |
CN1481251A (zh) | 2004-03-10 |
MXPA03005526A (es) | 2003-10-06 |
JP2005500981A (ja) | 2005-01-13 |
CA2431919A1 (en) | 2002-07-25 |
AR031931A1 (es) | 2003-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20042680L (no) | Fremgangsmater for fremstilling av O-demetylvenflaxine | |
FI20000564A (fi) | Menetelmä nanolaminaattien valmistamiseksi | |
NO20030012L (no) | Fremgangsmåte for fremstilling av substituerte oktanoylamider | |
PL376454A1 (en) | 1-acyl-pyrrolidine derivatives for the treatment of viral infections | |
DK1147083T3 (da) | Arylpiperazinyl-cyclohexylindolderivater til behandling af depression | |
NO20040253L (no) | Fremgangsmater for behandling av leverfibroser | |
NO20040027L (no) | Fremgangsmate for fremstillingen av escitalopram | |
DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
NO20023482D0 (no) | Fremgangsmåte for behandling av stoffmisbruk | |
AU2001269704A1 (en) | Oxazinoquinolones useful for the treatment of viral infections | |
NO20034123L (no) | Fremgangsmåte for behandling av brennstoff | |
NO20026219L (no) | Forbindelser for behandling av svekket fundisk relaksasjon | |
FI20012170A0 (fi) | Menetelmä lauhteiden käsittelemiseksi | |
NO20035538D0 (no) | Fremgangsmåte for fremstilling av zaleplon | |
PT1220858E (pt) | Oxazinoquinolonas uteis para o tratamento de infeccoes virais | |
NO20022816D0 (no) | Behandling av virale infeksjoner ved anvendelse av Levovirin | |
DE60227963D1 (de) | Behandlungssystem | |
NO20040087L (no) | Fremgangsmate for behandling av sovnloshet | |
NO20032769D0 (no) | Kombinasjonsmetode for behandling av virale infeksjoner | |
DK1268482T3 (da) | Pyranoindoler til behandling af glaukom | |
NO20012541D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
DE60140597D1 (de) | Vakuumbehandlungsverfahren | |
NO20030515D0 (no) | Fremgangsmåte for fremstilling av dinapsolin | |
DK1200447T3 (da) | Oxazinocarbazoler til behandling af CNS-sygdomme | |
NO20022253D0 (no) | Middel til behandling av hepatitt C |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |